Statement on the funding of Cochrane Oral Health

In August 2021 we learned that National Institute for Health Research (NIHR) funding to Cochrane Review Groups will cease in March 2023. We are grateful to have benefitted from many years of stable funding from the UK’s NIHR to support Cochrane Oral Health. However, we are also saddened that the huge number of people who are part of our group across the world will most likely lose the core editorial base team who hold the group together and support the production of Cochrane Reviews on oral health. Cochrane is currently in the process of developing a new model for managing the production and publication of systematic reviews. As a valued member of Cochrane you can join in that discussion here.

At present, it is unclear what the future holds and what other funding opportunities may be available to us, but our current NIHR funding remains in place until March 2023 and we will continue to fulfil our obligations to the funder by continuing to undertake high-quality systematic reviews to inform decision making.

Over the next few weeks we will work to identify which priority reviews can be realistically supported to completion in the given timeframe. We will contact lead authors of these reviews soon. This doesn’t preclude other review groups continuing to work on their reviews.

We will not register any new review titles to new/inexperienced author teams. However, it is possible that we may make a small number of exceptions for author teams with a proven track record and adequate support to complete reviews prior to March 2023.